U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07605780) titled 'TAVI in LOW RISK in the REAL WORLD' on April 15.
Brief Summary: The primary objective is to assess all-cause mortality, the occurrence of stroke, or rehospitalization for cardiovascular causes in low-risk "all-comers" patients following percutaneous aortic valve replacement
Study Start Date: Dec. 13, 2024
Study Type: OBSERVATIONAL
Condition:
Aortic Valve Stenosis
Recruitment Status: COMPLETED
Sponsor: Centro Cardiologico Monzino
Published by HT Digital Content Services with permission from Health Daily Digest....